Clene Inc

NASDAQ:CLNN 4:00:00 PM EDT

1.54

+0.05 (+3.36%)

5:20:53 PM EDT: $1.55 +0.01 (+0.65%)

Market Cap (Intraday)	113.69M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.14 Million
Adjusted EPS	-$0.13

See more estimates

10-Day MA	$1.53
50-Day MA	$1.21
200-Day MA	$2.23

See more pivots

Clene Inc Stock, NASDAQ:CLNN

6550 South Millrock Drive, Suite G50, Salt Lake City, Utah 84121

United States of America

Phone: +1.801.676.9695

Number of Employees: 102

http://www.clene.com

Description

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutics for neurodegenerative diseases. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded on August 12, 2020 and is headquartered in Salt Lake City, UT.